Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesBeginning Cash BalanceBeginning Cash BalanceCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Change in Cash (2016 - 2025)

BioCorRx (BICX) has disclosed Change in Cash for 16 consecutive years, with -$148328.0 as the latest value for Q4 2025.

  • Quarterly Change in Cash fell 268.66% to -$148328.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $51327.0 through Dec 2025, up 125.01% year-over-year, with the annual reading at $51327.0 for FY2025, 125.01% up from the prior year.
  • Change in Cash hit -$148328.0 in Q4 2025 for BioCorRx, down from $175816.0 in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $1.3 million in Q1 2021 to a low of -$1.2 million in Q2 2021.
  • Historically, Change in Cash has averaged -$22634.6 across 5 years, with a median of -$7329.0 in 2023.
  • Biggest five-year swings in Change in Cash: tumbled 1892.9% in 2023 and later surged 2224.66% in 2025.
  • Year by year, Change in Cash stood at -$659619.0 in 2021, then skyrocketed by 100.77% to $5086.0 in 2022, then crashed by 1892.9% to -$91187.0 in 2023, then soared by 196.44% to $87943.0 in 2024, then crashed by 268.66% to -$148328.0 in 2025.
  • Business Quant data shows Change in Cash for BICX at -$148328.0 in Q4 2025, $175816.0 in Q3 2025, and $87730.0 in Q2 2025.